Clinical trials
Completed Uveitis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
150 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 3 |
| 2002 | 5 |
| 2003 | 2 |
| 2004 | 3 |
| 2005 | 6 |
| 2006 | 6 |
| 2007 | 9 |
| 2008 | 8 |
| 2009 | 10 |
| 2010 | 9 |
| 2011 | 6 |
| 2012 | 2 |
| 2013 | 11 |
| 2014 | 4 |
| 2015 | 6 |
| 2016 | 5 |
| 2017 | 11 |
| 2018 | 3 |
| 2019 | 5 |
| 2020 | 4 |
| 2021 | 3 |
| 2022 | 6 |
| 2023 | 2 |
| 2024 | 5 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 150 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Eye Institute (NEI) | 33 |
| St. Franziskus Hospital | 7 |
| Assistance Publique - Hôpitaux de Paris | 5 |
| Clearside Biomedical, Inc. | 5 |
| JHSPH Center for Clinical Trials | 4 |
| Oregon Health and Science University | 4 |
| University of California, San Francisco | 4 |
| AbbVie | 3 |
| Duke University | 3 |
| Hospices Civils de Lyon | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Uveitis | 150 |
| Uveitis, Intermediate | 23 |
| Macular Edema | 22 |
| Uveitis, Posterior | 19 |
| Panuveitis | 15 |
| Uveitis, Anterior | 15 |
| Inflammation | 12 |
| Behcet Syndrome | 9 |
| Arthritis, Juvenile | 5 |
| Autoimmune Diseases | 5 |
Trials
Showing 1 to 25 of 150. Each trial links to its page on Pharma Observatory.
50 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.